| Name | DB07107 |
|---|
| Description | DB07107 is a potent drug resistant T315I mutant Bcr-Abl tyrosine kinase inhibitor. DB07107 is also a potent Akt1 inhibitor with an IC50 value of 360 nM[1][2]. |
|---|---|
| Related Catalog | |
| Target |
Bcr-AblT315I Akt1:360 nM (IC50) |
| In Vitro | DB07107 is more effective in blocking drug-resistant T315I mutant than the wild-type Bcr-Abl. DB07107 (C23H22N4O) from DrugBank showed the highest binding energy with XP score of -14.045 kcal/mol[1]. |
| References |
| Molecular Formula | C23H22N4O |
|---|---|
| Molecular Weight | 370.45 |
| Hazard Codes | Xi |
|---|